Dovato 50-300 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DB25FP64N
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $25,788
Award facts
- Contract value 100% obligated
- $25,787.83 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on August 26, 2025, for the supply of DOVATO 50-300 mg tablets in quantities of 30 tablets per unit, with a ceiling value of $25,787.83. This is a firm fixed-price delivery order with an ultimate completion date of August 27, 2025, and represents a non-competitive, non-set-aside award. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026.
DOVATO is an antiretroviral medication used in the treatment of human immunodeficiency virus (HIV) infection, reflecting the DLA's ongoing procurement of critical pharmaceutical products to support military medical readiness and veteran healthcare systems. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen maintains a substantial portfolio of federal contracts encompassing a broad range of brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. The company's selection for this award underscores its established capability to meet federal procurement requirements and its role as a key vendor within the Defense Health Agency's pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DB25FP64N?
SPE2DB25FP64N was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 26, 2025.
How much is contract SPE2DB25FP64N worth?
The government has obligated $25,788 on SPE2DB25FP64N.
Is contract SPE2DB25FP64N an order under another contract?
Yes. SPE2DB25FP64N is a delivery order under SPE2DB20D1109, an indefinite delivery contract.
Was contract SPE2DB25FP64N competed?
The extent of competition for SPE2DB25FP64N was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award